Information about Prezista Oral Solution (Darunavir)
Prezista is a medication containing the active ingredient darunavir, which is an antiretroviral drug used to treat HIV-1 infection. The oral solution form is designed for individuals who may have difficulty swallowing tablets, such as children or adults with swallowing difficulties. Darunavir works by inhibiting the protease enzyme, preventing the virus from maturing and replicating effectively.
Product Highlights
- Prezista oral solution is indicated for the treatment of HIV-1 infection in both adults and pediatric patients aged 3 years and older, as part of a combination antiretroviral regimen.
- It is often used for patients who have previously been treated for HIV and need an alternative regimen due to resistance or other issues.
Key Ingredient
Key Benefits
- Prezista helps lower the viral load (amount of HIV in the blood), which reduces the risk of transmitting HIV to others.
- By reducing HIV replication, Prezista helps restore and preserve immune system function.
- When used in combination with other antiretroviral drugs, it is generally well-tolerated in many patients.
Direction of Use
- Prezista oral solution should be taken exactly as prescribed by a healthcare provider.
- Adults and children over 3 years of age should follow the specific dosage instructions provided by their doctor.
- It is usually taken with food to improve absorption.
- The prescribed dose may vary based on age, weight, and the patient’s overall health condition.
Safety Concerns
- Prezista can cause liver problems, including elevated liver enzymes and hepatitis. Patients should be monitored for liver function.
- Some people may experience severe allergic reactions, including rash, itching, or swelling.
- Prezista may interact with other medications, so it is important to inform the healthcare provider of all other drugs being taken.
- Prezista should be used cautiously in patients with kidney disease.
Avoid Prezista Oral Solution (Darunavir) If
- Prezista should not be used during the first trimester of pregnancy unless absolutely necessary, as its safety during pregnancy has not been well established.
- It should be avoided or used with caution in patients with severe liver problems or liver disease.
- Do not use if allergic to darunavir or any other components of the formulation, especially those with known hypersensitivity to protease inhibitors.
- Avoid use with medications that significantly interact with darunavir, particularly those that may increase or decrease its levels to unsafe levels.
